MARKETING I KONSULTACJE FARMACEUTYCZNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
MARKETING I KONSULTACJE FARMACEUTYCZNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
A
HighestReliability
A - HighestIncorporation date
24/07/2002Share capital
50,000.00 PLNPrimary activity
Dispensing chemist in specialized stores (47.73.Z - PKD 2007)Representatives
1Representatives rights
KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE (REPREZENTACJA SAMOISTNA)Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
Renata Alicja Cieniawa-Algerowicz | Procurator |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
357,935Net Profit (zł)
357,935Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 47,493,198 |
| 67,712 |
| -14,155 |
| 0.19 |
| 3.70 |
| -0.03 |
| 9,197,303 |
| 3,375,163 |
| 0 |
| 84,459 |
| 2023 |
|---|
| 51,430,514 |
| -684,145 |
| -684,145 |
| 0.16 |
| 3.52 |
| -1.33 |
| 8,513,158 |
| 3,362,806 |
| 0 |
| 30,873 |
| 2024 |
|---|
| 56,294,108 |
| 372,144 |
| 357,935 |
| 0.16 |
| 3.31 |
| 0.64 |
| 8,871,092 |
| 3,807,496 |
| 0 |
| - |
| 2024 |
|---|
| 56,294,108 |
| 372,144 |
| 357,935 |
| 0.16 |
| 3.31 |
| 0.64 |
| 8,871,092 |
| 3,807,496 |
| 0 |
| - |
Turnover (zł)
2024
Turnover (zł)
56,294,108 zł
9 % *
Profit before tax (zł)
372,144 zł154 % *
Net Profit (zł)
357,935 zł152 % *
Working capital requirement (%)
0.16 
0.00 % *
Liquidity ratio
3.31 
-5.97 % *
Net profitability (%)
0.64 %148.12 % *
Equity (zł)
8,871,092 zł4 % *
Current liabilities (zł)
3,807,496 zł13 % *
Non current liabilities (zł)
0 zł- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Order report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
MARKETING I KONSULTACJE FARMACEUTYCZNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
05/06/2025 | OD 01.01.2024 DO 31.12.2024 |
27/06/2024 | OD 01.01.2023 DO 31.12.2023 |
05/09/2023 | OD 01.01.2022 DO 31.12.2022 |
26/10/2022 | OD 01.01.2021 DO 31.12.2021 |
26/10/2021 | OD 01.01.2020 DO 31.12.2020 |